Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Amgen's MariTide cardiovascular outcomes trial surfaces; OASIS pediatric migraine results holdOct 29Weekly roundup, 2 itemsAmgenmaridebart cafraglutideUpdated
Inhibikase names Kailera CMO Scott Wasserman to board, Berman resignsOct 20PeopleIKT-001Inhibikase Therapeutics
Sign inSign in